Provided by Tiger Fintech (Singapore) Pte. Ltd.

INCANNEX HEALTHCARE LTD

0.2094
+0.00251.21%
Post-market: 0.20960.0002+0.10%16:59 EDT
Volume:9.26M
Turnover:1.93M
Market Cap:19.62M
PE:-0.17
High:0.2102
Open:0.2100
Low:0.2059
Close:0.2069
Loading ...

Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial

TipRanks
·
14 Mar

Incannex Healthcare Prices $12.5 Million Private Stock Offering

MT Newswires Live
·
08 Mar

BRIEF-Incannex Healthcare Inc. Announces Pricing Of $12.5 Million Private Placement Priced At The Market Under Nasdaq Rules

Reuters
·
08 Mar

Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules

THOMSON REUTERS
·
08 Mar

Press Release: Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules

Dow Jones
·
08 Mar

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2025

Newsfile
·
19 Feb

BRIEF-Incannex Healthcare Reports Fiscal Second Quarter Results

Reuters
·
14 Feb

Incannex Healthcare Inc Qtrly Loss per Share $0.33

THOMSON REUTERS
·
14 Feb

Press Release: Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates

Dow Jones
·
14 Feb

Incannex Healthcare Appoints Alison Wimms, Ph.d. to Newly Formed Ihl-42X Obstructive Sleep Apnea (Osa) Clinical Advisory Board

THOMSON REUTERS
·
04 Feb

Incannex Healthcare Appoints Alison Wimms, Ph.D. to Newly Formed IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board

GlobeNewswire
·
04 Feb

Incannex announces results from PK study of IHL-42X

TIPRANKS
·
23 Jan

Incannex Healthcare Inc - No Serious Adverse Events Reported in Ihl-42X Study

THOMSON REUTERS
·
23 Jan

Incannex Healthcare Announces Positive Topline Results From Pharmacokinetics (Pk) Study of Ihl-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep Apnea

THOMSON REUTERS
·
23 Jan

Incannex Healthcare Inc - Ihl-42X Achieves Similar Pk and Drug Exposure Levels to Rld

THOMSON REUTERS
·
23 Jan